 Jefferey Beaver
Managing Director
Mr. Beaver has thirty years of diverse financial and management experience in both investment banking and corporate environments. His financial, analytic, negotiating and general manageent skills enable him to assist clients ina full range of assignments.
Mr. Beaver spent his early career with the U.S. Investment Management and Merger and Acquisition divisions of the U.K.-based merchant bank, Schroders plc, where he rose to the position of anaging Director. Following the 1986 acquisition of Schroders' U.S. banking activities by the Industrial Bank of Japan, he assumed the posistion of Senior Vice President and Group Head of IBJ Schroder's Corporate Finance Division. Under Mr. Beaver's leadership over the ensuing years, the Corporate Finance Division completed a score of transactions for domestic and multinational clients in industrial sectors ranging from healthcare and technology to basic materials.
In 1994, Mr. Beaver was appointed CEO of Cambridge Biotech Corporation, a Massachussetts biotechnology company which was experiencing financial difficulties. As CEO, and then executive Chairman, he presided over a Chapter 11 filing, cost reductions, asset sales, a recapitalization and other aspects of the bankruptcy process. The Company's reorganization was completed in October, 1996, and Mr. Beaver now serves as non-executive Chairman of Aquila Biopharmaceuticals, a new company formed to continue Cambridge's biopharmaceutical business. Mr. Beaver joined CoView in 1996.
Mr. Beaver holds a BA degree from Princeton University and an MBA from New York University. He is a Chartered Financial Analyst.
You may contact Mr. Beaver at JBeaver@CoViewCap.com.
|
